Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

GNRH Receptor

The gonadotropin-releasing hormone receptor (GnRHR), also known as the luteinizing hormone releasing hormone receptor (LHRHR), is a member of the seven-transmembrane, G-protein coupled receptor (GPCR) family. It is the receptor of gonadotropin-releasing hormone (GnRH). The GnRHR is expressed on the surface of pituitary gonadotrope cells as well as lymphocytes, breast, ovary, and prostate.

  • Linzagolix choline
    T257421321816-57-2
    Linzagolix choline is an orally available non-peptide gonadotropin-releasing hormone (GnRH) antagonist. It can be used to study pain associated with uterine fibroids and endometriosis.
    • $195
    In Stock
    Size
    QTY
  • Opigolix
    T17301912587-25-8
    Opigolix, a Gonadotropin-releasing hormone receptor antagonist, treats hormone-dependent conditions by inhibiting the actions of gonadotropin-releasing hormone (GnRH).
    • $293 TargetMol
    In Stock
    Size
    QTY
  • Linzagolix
    T27837935283-04-8
    Linzagolix is a small-molecule, non-peptide, orally active gonadotropin-releasing hormone antagonist (GnRH antagonist) which is under development by Kissei Pharmaceutical and ObsEva for the treatment of uterine fibroids, endometriosis, and adenomyosis. As of December 2020, it is under review for approval for uterine fibroids, is in phase III clinical trials for endometriosis, and is in phase II clinical studies for adenomyosis.
    • $48
    In Stock
    Size
    QTY
  • Goserelin acetate
    T4102145781-92-6
    Goserelin acetate (Fertilan) is a synthetic long-acting agonist of gonadotropin-releasing hormone, used in treatments of cancer.
    • $41
    In Stock
    Size
    QTY
  • Degarelix acetate(214766-78-6 free base)
    T10988L934016-19-0
    Degarelix acetate is a competitive and reversible antagonist of gonadotropin-releasing hormone receptor (GnRHR) .
    • $70
    In Stock
    Size
    QTY
  • (R)-Elagolix
    T11174834153-87-6
    (R)-Elagolix (NBI-56418) is a short-acting, nonpeptide, GnRH antagonist with an IC50 and Ki of 0.25 and 3.7 nM, respectively. administered orally, that unlike injectable depot GnRH agonists and antagonists, produces a dose-dependent suppression of ovarian estrogen production, that is, from partial suppression at lower doses to full suppression at higher doses.
    • $32
    In Stock
    Size
    QTY
  • Buserelin Acetate (57982-77-1 free base)
    TP130768630-75-1
    Buserelin Acetate (57982-77-1 free base) (Buserelin Acetate) is an agonist of gonadotropin-releasing hormone receptor(GnRHR).
    • $35
    In Stock
    Size
    QTY
  • Elagolix sodium
    T5031832720-36-2
    Elagolix sodium (NBI-56418 sodium) is a GnRH receptor (GnRHR) antagonist ( IC50 and Ki of 0.25 and 3.7 nM, respectively).
    • $38
    In Stock
    Size
    QTY
  • Cetrorelix Acetate
    T5520145672-81-7
    Cetrorelix Acetate is gonadotropin-releasing hormone (GnRH) receptor antagonist with an IC50 of 1.21 nM.
    • $40
    In Stock
    Size
    QTY
  • Deslorelin acetate(57773-65-6 free base)
    TP2323L
    Deslorelin acetate(57773-65-6 free base) is a gonadotropin releasing hormone super-agonist (GnRH agonist)
    • $85
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • Lecirelin acetate(61012-19-9 free base)
    TP1434L
    Lecirelin acetate is a synthetic GnRH (gonadotropin releasing hormone) analogue which shows a great efficacy in the treatment of bovine ovarian follicular cysts.
    • $68
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • Triptorelin acetate(57773-63-4 free base)
    T21410140194-24-7
    Triptorelin acetate(57773-63-4 free base) (CL 118,532) is used as a GnRH agonist. It decreases pituitary secretion of gonadotropins luteinizing hormone (LH) and follicle-stimulating hormone (FSH) by causing constant stimulation of the pituitary. Triptorelin acetate(57773-63-4 free base) may be used in the treatment of hormone-responsive cancers such as breast cancer or prostate cancer, precocious puberty, estrogen-dependent conditions, and assisted reproduction.
    • $50
    In Stock
    Size
    QTY
  • Relugolix
    T3630737789-87-6
    Relugolix (RVT-601) is an orally available, non-peptide gonadotropin-releasing hormone (GnRH or luteinizing hormone-releasing hormone (LHRH)) antagonist, with potential antineoplastic activity. Relugolix competitively binds to and blocks the GnRH receptor in the anterior pituitary gland, which both prevents GnRH binding to the GnRH receptor and inhibits the secretion and release of both luteinizing hormone (LH) and follicle stimulating hormone (FSH). In males, the inhibition of LH secretion prevents the release of testosterone from Leydig cells in the testes. Since testosterone is required to sustain prostate growth, reducing testosterone levels may inhibit hormone-dependent prostate cancer cell proliferation.
    • $31
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • Alarelin Acetate
    T149479561-22-1
    Alarelin Acetate is a synthetic GnRH agonist which can directly inhibit proliferation and DNA synthesis of rat GSMC through GnRH receptors.
    • $53
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • Histrelin acetate
    TP2107L220810-26-4
    Histrelin acetate is a nonapeptide analog of gonadotropin-releasing hormone (GnRH) with added potency. It acts on particular cells of the pituitary gland called gonadotropes when present in the bloodstream. Histrelin stimulates these cells to release luteinizing hormone and follicle-stimulating hormone. Thus it is considered a gonadotropin-releasing hormone agonist or GnRH agonist.
    • $80
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • Cetrorelix diacetate
    T5520L130143-01-0
    Cetrorelix diacetate (NS-75A) is is a gonadotropin-releasing hormone antagonist. It works by blocking the action of GnRH upon the pituitary, thus rapidly suppressing the production and action of luteinizing hormone (LH) and follicle-stimulating hormone (FSH).
    • $48
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • Abarelix
    T10217L183552-38-7
    Abarelix (PPI 149) is a potent gonadotrophin-releasing hormone (GnRH) antagonist, which is used for prostate cancer treatment.
    • $35
    In Stock
    Size
    QTY
  • Nafarelin acetate(76932-56-4 free base)
    T2130976932-60-0
    Nafarelin acetate(76932-56-4 free base) (RS-94991-298) is a GnRH agonist that acts as an analog of GnRH. Nafarelin acetate(76932-56-4 free base) causes a decrease in the pituitary secretion of gonadotropins luteinizing hormone (LH) and follicle-stimulating hormone (FSH). It may be used in the treatment of estrogen-dependent conditions.
    • $50
    In Stock
    Size
    QTY
  • LGnRH-III, lamprey acetate(147859-97-0 free base)
    TP1700L
    LGnRH-III, lamprey acetate is an evolutionarily conserved member of the GnRH family, can stimulate the secretion of gonadotropins, it stimulates the secretion of both luteinizing and follicle-stimulating hormones.
    • $133
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • AG 045572
    T22025263847-55-8
    AG 045572 is a potent GnRH receptor antagonist that inhibits the GnRH receptor in humans and rats with Ki values of 6.0 nM and 3.8 nM, respectively.AG 045572 is metabolized by CYP3A and inhibits testosterone.
    • $123
    In Stock
    Size
    QTY
  • Leuprolide Acetate (53714-56-0 free base)
    T502174381-53-6
    Leuprolide Acetate (53714-56-0 free base) (Leuprorelin acetate) is an agonist at pituitary GnRH receptors. Leuprolide Acetate (53714-56-0 free base) is a gonadotropin-releasing hormone (GnRH) analog used to treat a wide range of sex hormone-related disorders including advanced prostatic cancer, endometriosis, and precocious puberty. Leuprolide Acetate (53714-56-0 free base) acts primarily on the anterior pituitary, inducing a transient early rise in gonadotrophin release. With continued use, Leuprolide Acetate (53714-56-0 free base) causes pituitary desensitization and or down-regulation, leading to suppressed circulating levels of gonadotrophins and sex hormones.By interrupting the normal pulsatile stimulation of, and thus desensitizing, the GnRH receptors, it indirectly downregulates the secretion of gonadotropins luteinizing hormone (LH) and follicle-stimulating hormone (FSH), leading to hypogonadism and thus a dramatic reduction in estradiol and testosterone levels in both sexes.
      Inquiry
      TargetMol | Citations Cited
    • Ganirelix Acetate
      TP2337123246-29-7
      Ganirelix Acetate is a gonadotropin-releasing hormone (GnRH) receptor antagonist
      • $80
      In Stock
      Size
      QTY
      TargetMol | Inhibitor Sale
    • Phoenixin-14
      T804221415039-79-0
      Phoenixin-14 (PNX-14), an active endogenous isoform, induces an anxiolytic effect by activating the AHA GnRH system in mice and protects against ischemia/reperfusion-induced cytotoxicity in microglia [1] [2].
      • Inquiry Price
      Size
      QTY
    • Degarelix
      T10988214766-78-6
      Degarelix is a competitive and reversible gonadotropin-releasing hormone receptor (GnRHR) antagonist.
      • $847
      Backorder
      Size
      QTY
    • GnRH-R antagonist 1
      T724922826273-90-7
      GnRH-R antagonist 1 (Compound 21a), is an orally active, membrane-permeable agent with a high binding affinity (IC50=0.57 nM) and potent in vitro antagonistic efficacy (IC50=2.18 nM). It is utilized in research focused on advanced prostate cancer and the prevention of premature LH surges [1].
      • $2,420
      Backorder
      Size
      QTY
    • LHRH
      T8011635263-73-1
      Luteinizing hormone-releasing hormone (LHRH) is a neuropeptide produced in the hypothalamus that plays a pivotal role in regulating reproduction and has applications in cancer research [1].
      • Inquiry Price
      Size
      QTY